PAPER Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE
SEARCH RESULTS
329939 RESULTS
PAPER Zilkens RR, Duke J, Horner B, Semmens JB, Bruce DG
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849590PAPER Verlinden VJ, van der Geest JN, Hofman A, Ikram MA
Cognition and gait show a distinct pattern of association in the general population.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849591PAPER Solomon A, Ngandu T, Soininen H, Hallikainen MM, Kivipelto M, Laatikainen T
Validity of dementia and Alzheimer disease diagnoses in Finnish national registers.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849592PAPER Blom K, Emmelot-Vonk MH, Koek HL
The influence of vascular risk factors on cognitive decline in patients with dementia: A systematic review.
Maturitas. 2013 Oct;76(2):113-7. PubMed: 23849703PAPER Zhang J, Cao Q, Li S, Lu X, Zhao Y, Guan JS, Chen JC, Wu Q, Chen GQ
3-hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism.
Biomaterials. 2013 Oct;34(30):7552-62. PubMed: 23849878PAPER Phillips NR, Simpkins JW, Roby RK
Mitochondrial DNA deletions in Alzheimer's brains: A review.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850329PAPER Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H
CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850330PAPER Hamilton JM, Salmon DP, Raman R, Hansen LA, Masliah E, Peavy GM, Galasko D
Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: Beyond cognition.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850331PAPER Hausner L, Tschäpe JA, Schmitt HP, Hentschel F, Hartmann T, Frölich L
Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850332PAPER Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, Weiner MW,
The future of blood-based biomarkers for Alzheimer's disease.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850333PAPER Wicklund MR, Duffy JR, Strand EA, Whitwell JL, Machulda MM, Josephs KA
Aphasia with left occipitotemporal hypometabolism: A novel presentation of posterior cortical atrophy?
J Clin Neurosci. 2013 Sep;20(9):1237-40. PubMed: 23850398PAPER Windisch M, Flunkert S, Havas D, Hutter-Paier B
Commentary to the recently published review "Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease" by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116-40.
Ageing Res Rev. 2013 Jul 10;12(4):852-854. PubMed: 23851053PAPER Mesulam MM
Cholinergic circuitry of the human nucleus basalis and its fate in alzheimer's disease.
J Comp Neurol. 2013 Jul 13; PubMed: 23852922PAPER Shahnawaz M, Sharoar MG, Shin SY, Park IS
Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio.
J Pept Sci. 2013 Sep;19(9):545-53. PubMed: 23853087Current Filters
No filters selected